Brett A. Cope, Chairman and CEO, reported "Powell delivered a strong third quarter, as operationally, the team continues to execute at a high level. Our gross profit dollars grew 8% despite roughly ...

August James Troendle, CEO, opened by stating that “RFP flow in Q2 continued to be strong, and we saw an increase in rate of decisions. Total pending RFP dollars were down on the quarter and our award ...

Medpace's second-quarter revenue increased 14% from the prior year, and its backlog conversion rate was 21%. Management increased its 2025 revenue guidance by 13% at the midpoint and raised its net ...